{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:49:08Z","timestamp":1793332148506,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.survophthal.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T21:00:15Z","timestamp":1501794015000},"page":"340-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Treatment of ocular rosacea"],"prefix":"10.1016","volume":"63","author":[{"given":"Edward J.","family":"Wladis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-7235","authenticated-orcid":false,"given":"Alejandro P.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2017.07.005_bib1","first-page":"2506","article-title":"Tear fluid gelat. inase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea","volume":"40","author":"Afonso","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2017.07.005_bib2","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0161-6420(97)30015-3","article-title":"Ocular rosacea: patient characteristics and follow-up","volume":"104","author":"Akpek","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2017.07.005_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0974-9233.63070","article-title":"Spontaneous corneal perforation in ocular rosacea","volume":"17","author":"Al Arfaj","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1542-0124(12)70121-0","article-title":"Ocular rosacea","volume":"3","author":"Alvarenga","year":"2005","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2017.07.005_bib5","first-page":"544","article-title":"Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline","volume":"8","author":"Arman","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.2006.091579","article-title":"Short term oral minocycline treatment of meibomianitis","volume":"90","author":"Aronowicz","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin","volume":"23","author":"Bakar","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib8","first-page":"1","article-title":"Systemic therapy for rosacea","volume":"12","author":"Baldwin","year":"2007","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.survophthal.2017.07.005_bib9","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0161-6420(96)30412-0","article-title":"The efficacy of topical metronidazole in the treatment of ocular rosacea","volume":"103","author":"Barnhorst","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2017.07.005_bib10","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(97)30014-1","article-title":"Inflammatory cytokines in the tears of patients with ocular rosacea","volume":"104","author":"Barton","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2017.07.005_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13555-016-0106-9","article-title":"Erythema of rosacea impairs health-related quality of life: results of a meta-analysis","volume":"6","author":"Bewley","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.survophthal.2017.07.005_bib12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/OPTH.S109663","article-title":"The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye","volume":"10","author":"Blackie","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0190-9622(93)70065-2","article-title":"The Demodex mite population in rosacea","volume":"28","author":"Bonnar","year":"1993","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib15","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.fsc.2012.11.004","article-title":"Rosacea: pathophysiology and management principles","volume":"21","author":"Chauhan","year":"2013","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.survophthal.2017.07.005_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.coph.2012.06.002","article-title":"New developments in Toll-like receptor targeted therapeutics","volume":"12","author":"Connolly","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1167\/iovs.14-15764","article-title":"Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction","volume":"56","author":"Craig","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2017.07.005_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-015-0077-2","article-title":"Perceptions on the psychological impact of facial erythema associated with rosacea: results of international survey","volume":"5","author":"Dirschka","year":"2015","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.survophthal.2017.07.005_bib20","first-page":"120","article-title":"Results of a national rosacea patient survey: common issues that concern rosacea sufferers","volume":"8","author":"Elewski","year":"2009","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.phrs.2011.06.013","article-title":"The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease","volume":"64","author":"Federici","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.survophthal.2017.07.005_bib22","first-page":"153","article-title":"Azithromycin reduces inflammation in a rat model of acute conjunctivitis","volume":"19","author":"Fernandez-Robredo","year":"2013","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2017.07.005_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvp332","article-title":"Targeting cancer vasculature via endoglin\/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours","volume":"86","author":"Fonsatti","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.survophthal.2017.07.005_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.08.010","article-title":"Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management","volume":"239","author":"Gambuzza","year":"2011","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.ico.0000244870.62384.79","article-title":"Clinical treatment of ocular demodecosis by lid scrub with tea tree oil","volume":"26","author":"Gao","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2017.07.005_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00003226-200304000-00009","article-title":"The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics","volume":"22","author":"Ghanem","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2017.07.005_bib27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2174\/138161210790963841","article-title":"Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics","volume":"16","author":"Gomariz","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.survophthal.2017.07.005_bib28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/ceo.12033","article-title":"Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment","volume":"41","author":"Greiner","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","article-title":"Rosacea and its management: an overview","volume":"19","author":"Gupta","year":"2005","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd3203","article-title":"Targeting Toll-like receptors: emerging therapeutics?","volume":"9","author":"Hennessy","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.survophthal.2017.07.005_bib31","first-page":"348","article-title":"Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life","volume":"6","author":"Huynh","year":"2013","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.survophthal.2017.07.005_bib32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e318207fc42","article-title":"Oral azithromycin for treatment of posterior blepharitis","volume":"30","author":"Igami","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2017.07.005_bib33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/112067210901900504","article-title":"In\u00a0vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis","volume":"19","author":"Iovieno","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3129\/i08-016","article-title":"Blepharitis: current strategies for diagnosis and management","volume":"43","author":"Jackson","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/jid.2012.14","article-title":"Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin","volume":"132","author":"Kanada","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajo.2007.01.054","article-title":"Corneal manifestations of ocular demodex infestation","volume":"143","author":"Kheirkhah","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib37","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/exd.13381","article-title":"Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel","volume":"26","author":"Kim","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0b013e318239aaea","article-title":"A\u00a0new system, the LipiFlow, for the treatment of meibomian gland dysfunction","volume":"31","author":"Lane","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2017.07.005_bib39","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1468-3083.2011.03995.x","article-title":"Clinical and laboratory study of ocular rosacea in northern Greece","volume":"25","author":"Lazaridou","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib40","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajo.2012.06.009","article-title":"Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction","volume":"154","author":"Lee","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib41","first-page":"31","article-title":"A\u00a0Guide to the ingredients and potential benefits of over-the-counter cleansers and moisturizers for rosacea patients","volume":"4","author":"Levin","year":"2011","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib42","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jaad.2016.12.043","article-title":"The burden of skin disease in the United States","volume":"76","author":"Lim","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib43","first-page":"336","article-title":"The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)","volume":"106","author":"Macsai","year":"2008","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2017.07.005_bib44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jid.2016.10.046","article-title":"TRPV4 mediates mast cell activation in cathelicidin-induced rosacea inflammation","volume":"137","author":"Mascarenhas","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib45","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e3181d836f3","article-title":"Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction","volume":"29","author":"Maskin","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2017.07.005_bib46","first-page":"1020","article-title":"Incorporating sustainability into the concept of optimal care","volume":"54","author":"Mileski","year":"2003","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.survophthal.2017.07.005_bib47","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib49","first-page":"187","article-title":"Rosacea: diagnosis and treatment","volume":"92","author":"Oge","year":"2015","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.survophthal.2017.07.005_bib50","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/CIA.S48955","article-title":"A\u00a0randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction","volume":"8","author":"Olenik","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.survophthal.2017.07.005_bib51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.optm.2010.01.015","article-title":"Rosacea and its ocular manifestations","volume":"82","author":"Oltz","year":"2011","journal-title":"Optometry"},{"key":"10.1016\/j.survophthal.2017.07.005_bib52","first-page":"904","article-title":"Treatment of ocular rosacea with 40 mg doxycycline in a slow release form","volume":"9","author":"Pfeffer","year":"2011","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.survophthal.2017.07.005_bib53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice. Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.survophthal.2017.07.005_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1997.03890370055009","article-title":"Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline","volume":"133","author":"Quarterman","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib55","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.eye.6702005","article-title":"Pathogenesis, clinical features and management of recurrent corneal erosions","volume":"20","author":"Ramamurthi","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2017.07.005_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000249558","article-title":"T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum","volume":"169","author":"Rufli","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.survophthal.2017.07.005_bib57","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00007890-199903150-00015","volume":"67","author":"Salmela","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.survophthal.2017.07.005_bib58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjd.15173","article-title":"Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel","volume":"176","author":"Schaller","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.survophthal.2017.07.005_bib60","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses","volume":"169","author":"Scott","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib61","first-page":"30","article-title":"The effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: an assessment","volume":"6","author":"Shim","year":"2013","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib62","doi-asserted-by":"crossref","first-page":"124548","DOI":"10.1155\/2012\/124548","article-title":"Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome","volume":"2012","author":"Siller","year":"2012","journal-title":"Neural Plast"},{"key":"10.1016\/j.survophthal.2017.07.005_bib63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/ICO.0000000000000051","article-title":"Treatment of ocular rosacea with once-daily low-dose doxycycline","volume":"33","author":"Sobolewska","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2017.07.005_bib64","first-page":"1703","article-title":"Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant","volume":"41","author":"Sobrin","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2017.07.005_bib65","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2133.2012.11037.x","article-title":"A\u00a0study on the epidemiology of rosacea in the U.K","volume":"167","author":"Spoendlin","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib66","first-page":"7846","article-title":"Antiangiogenic therapy of established tumors in human skin\/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide","volume":"61","author":"Takahashi","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2017.07.005_bib67","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjd.15122","article-title":"Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel","volume":"176","author":"Tan","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib68","first-page":"71","article-title":"Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices","volume":"93","author":"Tanghetti","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.survophthal.2017.07.005_bib69","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaad.2004.04.010","article-title":"Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life","volume":"51","author":"Tan","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13555-017-0176-3","article-title":"Topical treatment of rosacea with ivermectin inhibits gene expression of cathelicidin innate immune mediators, LL-37 and KLK5, in reconstructed and ex\u00a0vivo skin models","volume":"7","author":"Thibaut de Menonville","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.survophthal.2017.07.005_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/pho.2014.3819","article-title":"Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study","volume":"33","author":"Toyos","year":"2015","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.survophthal.2017.07.005_bib72","first-page":"CD003262","article-title":"Interventions for rosacea","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2017.07.005_bib73","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S0004-27492012000500016","article-title":"Ocular rosacea\u2013a review","volume":"75","author":"Vieira","year":"2012","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib74","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2013.04.042","article-title":"Ocular rosacea: common and commonly missed","volume":"69","author":"Vieira","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib75","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the national rosacea society expert committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib76","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/IOP.0b013e3182627ebc","article-title":"Intraductal meibomian gland probing in the management of ocular rosacea","volume":"28","author":"Wladis","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2017.07.005_bib77","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ophtha.2015.10.062","article-title":"Oral antibiotics for meibomian gland-related ocular surface disease: a report by the American academy of ophthalmology","volume":"123","author":"Wladis","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2017.07.005_bib78","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/IOP.0b013e318293764c","article-title":"Toll-like receptors and vascular markers in ocular rosacea","volume":"29","author":"Wladis","year":"2013","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2017.07.005_bib79","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1167\/iovs.16-20275","article-title":"Activation of p38 and Erk mitogen-activated protein kinases signaling in ocular rosacea","volume":"58","author":"Wladis","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2017.07.005_bib80","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/IOP.0b013e31824dd9d4","article-title":"Molecular biologic assessment of cutaneous specimens of ocular rosacea","volume":"28","author":"Wladis","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2017.07.005_bib81","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbamem.2015.11.003","article-title":"The human cathelicidin LL-37\u2013A pore-forming antibacterial peptide and host-cell modulator","volume":"1858","author":"Xhindoli","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.survophthal.2017.07.005_bib82","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2017.07.005_bib83","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2017.07.005_bib84","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3341\/kjo.2005.19.4.258","article-title":"The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction","volume":"19","author":"Yoo","year":"2005","journal-title":"Korean J Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625717300012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625717300012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:44:51Z","timestamp":1758541491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625717300012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0039625717300012"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2017.07.005","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of ocular rosacea","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}